1.
Spectrum of BCR-ABL Mutations and Treatment Outcomes in Imatinib-Resistant CML Patients: A Retrospective Analysis from a Tertiary Centre in South India. JOC [Internet]. 2025 Nov. 7 [cited 2025 Dec. 26];24(4):261-70. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1573